A phase I study of twice weekly pulse dose and daily low dose erlotinib as initial treatment for patients (pts) with EGFR-mutant lung cancers Meeting Abstract


Authors: Yu, H. A.; Sima, C. S.; Reales, D.; Jordan, S.; Rudin, C. M.; Kris, M. G.; Michor, F.; Pao, W.; Riely, G. J.
Abstract Title: A phase I study of twice weekly pulse dose and daily low dose erlotinib as initial treatment for patients (pts) with EGFR-mutant lung cancers
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901730
PROVIDER: wos
Notes: Meeting Abstract: 8017 -- Source: Wos